Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering

    NEXT STORY
    UPDATE – Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
    PREV STORY
    Nevada Gold Mines Provides Covid-19 Support for Local Communities
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019

    author_avatar
    NASDAQ Market News

    RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.

    Glen Rock, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 /Globe Newswire ...

    author_avatar
    NASDAQ Market News

    Centrexion Therapeutics to Announce CNTX-4975 Trial Results at the European League Against Rheumatism’s (EULAR) 2019 Annual European Congress of Rheumatology

    author_avatar
    NASDAQ Market News